Clinical trial
An Observational Clinical Study of AIGIV Use in Sporadic Cases of Systemic Anthrax
NCT03569514 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Clinical Study of AIGIV Use in Sporadic Cases of Systemic Anthrax
- Lead sponsor
- Emergent BioSolutions
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- August 31, 2027
- Enrollment
- 10 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.